The term iCGM refers to integrated CGM (iCGM), which are systems that meet specific and rigorous requirements of the FDA with published performance data verifying accuracy that are used to directly inform decision-making in the treatment of diabetes (i.e., insulin dosing) [32]. This evidence concerns the gene INS and diabetes mellitus.